Abbott ABT Medical Devices — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's medical devices — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Abbott's medical devices — total assets?
- Abbott (ABT) reported medical devices — total assets of $10.98B in Q1 2026.
- How has Abbott's medical devices — total assets changed year-over-year?
- Abbott's medical devices — total assets increased by 9.5% year-over-year, from $10.03B to $10.98B.
- What does medical devices — total assets mean?
- This metric represents the total economic resources controlled by the medical devices business segment, including property, plant, equipment, and intangible assets dedicated to the development and manufacturing of cardiovascular, diabetes, and neuromodulation technologies. It reflects the capital intensity required to support the segment's innovation pipeline and global supply chain operations. Tracking this asset base helps investors understand the scale of infrastructure and intellectual property deployed to sustain the segment's market position.